DocGo Inc.
DCGONasdaqCIK 1822359HealthcareFiscal year ends Dec 31
Reports and events: 116 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0510:32 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events | 0001628280-26-064740 |
| 2026-08-1720:35 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001628280-26-057394 |
| 2026-08-1720:24 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-057387 |
| 2026-07-3120:06 ET | 8-K | 3.01 Delisting notice | 0001628280-26-051396 |
| 2026-07-0220:17 ET | 8-K | 7.01 Regulation FD disclosure | 0001628280-26-046919 |
| 2026-06-1821:06 ET | 8-K | 5.07 Shareholder vote results | 0001628280-26-044414 |
| 2026-05-1120:32 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001628280-26-033563 |
| 2026-05-1120:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001822359-26-000020 |
| 2026-04-2220:06 ET | DEF 14A | Proxy statementPeriod 2026-06-16 | 0001213900-26-046600 |
| 2026-04-2201:32 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001822359-26-000017 |
| 2026-03-1620:30 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001628280-26-018214 |
| 2026-03-1620:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001822359-26-000009 |
| 2026-02-2621:13 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001409310-26-000004 |
| 2026-01-3022:12 ET | 8-K | 3.01 Delisting notice | 0001822359-26-000003 |
| 2025-12-1221:08 ET | 8-K | 7.01 Regulation FD disclosure | 0001822359-25-000080 |
| 2025-11-1021:39 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001628280-25-051102 |
| 2025-11-1021:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-051026 |
| 2025-10-2101:58 ET | 8-K/A | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-25-100516 |
| 2025-10-2021:01 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-100412 |
| 2025-08-0720:47 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001822359-25-000077 |
| 2025-08-0720:19 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001822359-25-000074 |
| 2025-06-1820:21 ET | 8-K | 5.07 Shareholder vote results | 0001822359-25-000062 |
| 2025-06-1220:22 ET | 8-K | 7.01 Regulation FD disclosure | 0001822359-25-000060 |
| 2025-05-0820:35 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001822359-25-000042 |
| 2025-05-0820:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001822359-25-000040 |
| 2025-04-2420:11 ET | DEF 14A | Proxy statementPeriod 2025-06-17 | 0001213900-25-035063 |
| 2025-02-2721:33 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001822359-25-000018 |
| 2025-02-2721:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001822359-25-000017 |
| 2024-12-2021:05 ET | 8-K | 7.01 Regulation FD disclosure | 0001822359-24-000119 |
| 2024-11-2921:14 ET | SC 13D/A | Ownership report, active investor, amended | 0001822359-24-000100 |
| 2024-11-0721:34 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001822359-24-000094 |
| 2024-11-0721:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001822359-24-000092 |
| 2024-09-3011:40 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001822359-24-000085 |
| 2024-08-0720:37 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001822359-24-000081 |
| 2024-08-0720:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001822359-24-000079 |
| 2024-06-1820:28 ET | 8-K | 5.07 Shareholder vote results | 0001822359-24-000058 |
| 2024-05-0820:36 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001822359-24-000045 |
| 2024-05-0820:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001822359-24-000043 |
| 2024-05-0720:46 ET | 8-K | 8.01 Other events | 0001822359-24-000037 |
| 2024-04-2520:19 ET | DEF 14A | Proxy statementPeriod 2024-06-18 | 0001213900-24-036220 |
| 2024-04-1011:26 ET | 8-K | 7.01 Regulation FD disclosure | 0001822359-24-000035 |
| 2024-03-0812:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001822359-24-000018 |
| 2024-02-2821:23 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001822359-24-000016 |
| 2024-02-2821:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001822359-24-000014 |
| 2024-01-3112:41 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001822359-24-000009 |
| 2024-01-1612:42 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001822359-24-000007 |
| 2024-01-1021:24 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001822359-24-000005 |
| 2023-11-0621:45 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001822359-23-000032 |
| 2023-11-0621:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001822359-23-000031 |
| 2023-10-2410:44 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001822359-23-000025 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.